Advertisement
Advertisement
December 23, 2013
Reverse Medical's Barrel Vascular Reconstruction Device Approved in Europe to Treat Intracranial Bifurcation Aneurysms
December 19, 2013—Reverse Medical Corporation (Irvine, CA) announced European CE Mark approval for commercialization of the Barrel vascular reconstruction device (VRD), which is intended for use with occlusive devices in the treatment of intracranial aneurysms. The company also announced the first European clinical case with the device and advised that it will begin commercialization in Europe through a network of distributors by mid 2014.
Commenting in Reverse Medical’s press release, Michel Piotin, MD, who is Director of the Department of Interventional Neuroradiology at Fondation Rothschild Hospital in Paris, France, stated, “Our first experience with the Barrel VRD in a wide-neck bifurcation intracranial aneurysm was impressive. The device tracked easily through tortuous anatomy, had excellent angiographic visibility, was easily and completely resheathable, and deployed very nicely. The device required no radial orientation maneuvers for accurate placement, providing a single device alternative to surgery, or to technically challenging ‘X-Y’ stenting for these complex bifurcation aneurysms.”
Advertisement
Advertisement
